MORONI, ELISABETTA MARIA
 Distribuzione geografica
Continente #
AS - Asia 1.475
NA - Nord America 1.132
EU - Europa 495
SA - Sud America 316
Continente sconosciuto - Info sul continente non disponibili 181
AF - Africa 26
OC - Oceania 2
Totale 3.627
Nazione #
US - Stati Uniti d'America 1.064
SG - Singapore 624
CN - Cina 303
BR - Brasile 243
IT - Italia 227
HK - Hong Kong 173
VN - Vietnam 146
FR - Francia 80
KR - Corea 53
IN - India 39
FI - Finlandia 37
DE - Germania 31
NL - Olanda 31
AR - Argentina 30
BD - Bangladesh 28
JP - Giappone 27
CA - Canada 23
GB - Regno Unito 22
MX - Messico 15
CO - Colombia 13
ID - Indonesia 11
ZA - Sudafrica 11
IL - Israele 9
EC - Ecuador 8
ES - Italia 8
IQ - Iraq 8
PL - Polonia 7
AL - Albania 6
CR - Costa Rica 6
MY - Malesia 6
PK - Pakistan 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
CL - Cile 5
IE - Irlanda 5
JM - Giamaica 5
PE - Perù 5
PH - Filippine 5
TR - Turchia 5
BB - Barbados 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
UA - Ucraina 4
UZ - Uzbekistan 4
BE - Belgio 3
CZ - Repubblica Ceca 3
EG - Egitto 3
NI - Nicaragua 3
NP - Nepal 3
PY - Paraguay 3
SE - Svezia 3
TN - Tunisia 3
BO - Bolivia 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
LK - Sri Lanka 2
LV - Lettonia 2
MA - Marocco 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GD - Grenada 1
GE - Georgia 1
GR - Grecia 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
MD - Moldavia 1
MF - Saint Martin 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
TH - Thailandia 1
Totale 3.444
Città #
Singapore 358
Santa Clara 316
Hong Kong 170
Hefei 130
San Jose 123
Ashburn 107
Milan 72
Lauterbourg 65
Beijing 57
Seoul 53
Los Angeles 49
Ho Chi Minh City 48
Dallas 38
Hanoi 34
Brescia 23
Lappeenranta 23
São Paulo 17
Tokyo 15
Mumbai 12
New York 12
Rio de Janeiro 11
Alzano Lombardo 10
Buffalo 10
Council Bluffs 10
Johannesburg 10
Da Nang 9
Frankfurt am Main 9
Houston 9
Philadelphia 9
Chicago 8
Florence 8
Minamishinagawa 8
Montreal 8
Nuremberg 8
Helsinki 7
Padova 7
Trieste 7
Turku 7
Atlanta 6
Brasília 6
Curitiba 6
Denver 6
Phoenix 6
Rome 6
San José 6
Belo Horizonte 5
Bengaluru 5
Campinas 5
Chennai 5
Warsaw 5
Amsterdam 4
Bridgetown 4
Brooklyn 4
Buenos Aires 4
Cirimido 4
Cleveland 4
Colombo 4
Falkenstein 4
Guangzhou 4
Guarulhos 4
Haiphong 4
Hải Dương 4
Kuala Lumpur 4
Lima 4
London 4
Mexico City 4
Miami 4
Pelotas 4
Porto Alegre 4
Quito 4
Tampa 4
Tashkent 4
Bergamo 3
Biên Hòa 3
Bogotá 3
Bologna 3
Brussels 3
Charleston 3
Dhaka 3
Dublin 3
Jakarta 3
Kingston 3
Kolkata 3
Las Vegas 3
Managua 3
Manaus 3
Naples 3
Ninh Bình 3
Orem 3
Osaka 3
Quận Một 3
Riyadh 3
San Diego 3
San Francisco 3
Scandicci 3
Seattle 3
Shenzhen 3
Sorrento 3
St Louis 3
The Bronx 3
Totale 2.116
Nome #
Design and Test of Molecules that Interfere with the Recognition Mechanisms between the SARS-CoV-2 Spike Protein and Its Host Cell Receptors 114
Point mutations of the mitochondrial chaperone TRAP1 affect its functions and pro-neoplastic activity 92
Conformational Dynamics of hAgo2 Silencing: Decoding Functional Divergence across Human Argonaute Paralogs 86
Target oriented-drug discovery: unraveling the molecular interaction between Leishmania Hsp90 and a celastrol carboxamide derivative 85
Frontiers and Challenges of Computing ncRNAs Biogenesis, Function and Modulation 84
The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein 75
Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design 72
Visualizing the Dynamics of a Protein Folding Machinery: The Mechanism of Asymmetric ATP Processing in Hsp90 and its Implications for Client Remodelling 70
N-Glycosylation-Induced Pathologic Protein Conformations as a Tool to Guide the Selection of Biologically Active Small Molecules 67
Design of allosteric stimulators of the HSP90 ATPase as novel anticancer leads 66
HIF1alfa-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia 64
Integrating Protein Interaction Surface Prediction with a Fragment-Based Drug Design: Automatic Design of New Leads with Fragments on Energy Surfaces 64
Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1 63
How aberrant N-glycosylation can alter protein functionality and ligand binding: An atomistic view 62
Insights from molecular dynamics simulations for the development of modulators of mitochondrial Hsp90 (Trap1) activity 60
Transcription factor protein interactomes reveal genetic determinants in heart disease 60
Editorial: Computational drug discovery for targeting of protein-protein interfaces—Volume II 60
Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1 58
Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1 56
N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease 55
Design and synthesis of cyclic peptides targeting Gas6 54
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 53
Atomistic Simulations of the Mechanisms of the Poorly Catalytic Mitochondrial Chaperone Trap1: Insights into the Effects of Structural Asymmetry on Reactivity 51
Conformational Behavior of SARS-Cov-2 Spike Protein Variants: Evolutionary Jumps in Sequence Reverberate in Structural Dynamic Differences 50
Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical Probes 48
Studying the Dynamics of a Complex G-Quadruplex System: Insights into the Comparison of MD and NMR Data 48
Disulfide-mediated tetramerization of TRAP1 fosters its antioxidant and pro-neoplastic activities 47
Evaluation of docking procedures reliability in affitins-partners interactions 47
Allosteric Regulation Points Control the Conformational Dynamics of the Molecular Chaperone Hsp90 47
Investigating Dynamic and Energetic Determinants of Protein Nucleic Acid Recognition: Analysis of the Zinc Finger Zif268-DNA Complexes 46
A Fe2+-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymes 46
Expedient Access to 2-Benzazepines by Palladium-Catalyzed C-H Activation: Identification of a Unique Hsp90 Inhibitor Scaffold 45
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization. 45
The Dynamics of the Folding Machinery 44
Machine Learning Prediction of Allosteric Drug Activity from Molecular Dynamics 44
Arrestins as Possible Drug Targets 44
Advancing Molecular Simulations: Merging Physical Models, Experiments, and AI to Tackle Multiscale Complexity 43
SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern 43
Structural determinants of cold activity and glucose tolerance of a family 1 glycoside hydrolase (GH1) from Antarctic Marinomonas sp. ef1 43
A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein 42
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 42
Molecular structure and enzymatic mechanism of the human collagen hydroxylysine galactosyltransferase GLT25D1/COLGALT1 41
molecular dynamics simulations reveal the mechanisms of allosteric activation of Hsp90 by designed ligands 40
Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors 38
MM/PBSA analysis of molecular dynamics simulations of bovine beta-lactoglobulin: free energy gradients in conformational transitions? 38
Cracking the chaperone code through the computational microscope 38
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 38
Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives 37
Exploiting conformational dynamics in drug discovery: Design of C-terminal inhibitors of Hsp90 with improved activities 35
The Structural Asymmetry of Mitochondrial Hsp90 (Trap1) Determines Fine Tuning of Functional Dynamics 35
Novel PARP-1 Inhibitor scaffolds disclosed by a dynamic structure-based pharmacophore approach 34
Structures, dynamics, complexes, and functions: From classic computation to artificial intelligence 34
Computational approaches meet experiments to design new allosteric ligands 33
Identification of DNA-binding protein target sequences by physical effective energy functions: Free energy analysis of lambda repressor-DNA complexes 33
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy 33
The Dynamics of Drug Discovery 33
Second generation of fucose-based DC-SIGN ligands: Affinity improvement and specificity versus Langerin 32
A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation 32
Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography 31
Dynamic-based discovery of new allosteric ligands targeting the Hsp90 C-terminal inhibitor binding site 31
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 31
Conformational regulation of Hsp90 though mutations and small molecules 31
A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation 31
Investigating dynamic and energetic determinants of protein nucleic acid recognition: Analysis of the zinc finger zif268-DNA complexes 30
Conformational regulation of Hsp90 through mutation and small molecules 30
Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors 30
Using QM/MM Molecular Dynamics to Model Reactivity in the mitochondrial Chaperone Trap1 29
Identification of a new scaffold for Hsp90 C-terminal inhibition 29
Molecular dynamics simulations of hsp90 with an eye to inhibitor design. 28
Impact of Mutations on NPAC Structural Dynamics: Mechanistic Insights from MD Simulations 28
Synthesis of Functionalized 2-(4-Hydroxyphenyl)-3-methylbenzofuran Allosteric Modulators of Hsp90 Activity 28
Assessment of Mutational Effects on Peptide Stability through Confinement Simulations 28
Modifying Hsp90 dynamics and functional relationships through rationally designed allosteric activators 28
Chemical and Biophysical Approaches to Allosteric Modulation 27
3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin Analogues 26
Structure and sequence determinants of aggregation investigated with molecular dynamics 26
Activation of Hsp90 activity and conformational dynamics through computationally designed allosteric ligands: functional implications 24
Structure and sequence determinants of aggregation investigated with molecular dynamics 22
Investigating allostery with atomistic biomolecular simulations 20
New allosteric modulators of molecular chaperone TRAP1 from the integration of computational biology, medicinal chemistry, and biophysics 15
Selective allosteric regulation of Leishmania braziliensis Hsp90 through a parasite-specific regulatory hub 14
Hijacking client instability to selectively disrupt HSP90-driven glucocorticoid receptor activation 11
An isotype-specific phosphorylation of Hsp90 rewires co-chaperone regulations 10
Totale 3.627
Categoria #
all - tutte 12.852
article - articoli 11.237
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 63
Totale 24.152


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202413 0 0 0 0 0 0 0 0 1 2 0 10
2024/20251.405 2 3 70 54 250 201 43 117 31 66 298 270
2025/20261.790 108 172 196 290 328 62 290 75 57 97 74 41
2026/2027419 116 97 206 0 0 0 0 0 0 0 0 0
Totale 3.627